Stockscreener 앱 받기
15.05
0.20%
-0.03
시간 외 거래:
14.91
-0.14
-0.93%
전일 마감가:
$15.08
열려 있는:
$15.03
하루 거래량:
9,609
Relative Volume:
0.09
시가총액:
$209.08M
수익:
$6.67M
순이익/손실:
$-47.55M
주가수익비율:
-10.03
EPS:
-1.5
순현금흐름:
$-17.44M
1주 성능:
+15.24%
1개월 성능:
+20.40%
6개월 성능:
+2,843%
1년 성능:
+2,843%
1일 변동 폭
$14.81
$15.32
1주일 범위
$13.16
$15.39
52주 변동 폭
$9.81
$21.40
Crescent Biopharma Inc Stock (CBIO) Company Profile
명칭
Crescent Biopharma Inc
전화
617-430-5595
주소
300 FIFTH AVENUE, WALTHAM, CA
CBIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CBIO
Crescent Biopharma Inc
|
15.05 | 253.08M | 6.67M | -47.55M | -17.44M | -1.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.61 | 109.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.19 | 82.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.23 | 58.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
911.98 | 56.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.77 | 43.62B | 447.02M | -1.18B | -906.14M | -6.1812 |
Crescent Biopharma Inc Stock (CBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-25 | 개시 | Jefferies | Buy |
| 2025-08-11 | 개시 | H.C. Wainwright | Buy |
| 2025-07-14 | 개시 | Wedbush | Outperform |
| 2025-06-25 | 개시 | Stifel | Buy |
| 2025-03-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-03-11 | 개시 | Noble Capital Markets | Outperform |
| 2024-07-26 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2023-12-22 | 개시 | CapitalOne | Overweight |
| 2021-11-12 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-04-29 | 재개 | Stephens | Overweight |
| 2021-02-10 | 개시 | Piper Sandler | Overweight |
| 2020-05-21 | 개시 | Raymond James | Outperform |
| 2019-11-14 | 개시 | ROTH Capital | Buy |
| 2019-08-05 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-08-05 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2019-08-05 | 다운그레이드 | SunTrust | Buy → Hold |
| 2019-04-12 | 개시 | Piper Jaffray | Overweight |
| 2019-01-04 | 개시 | Oppenheimer | Outperform |
| 2018-12-18 | 개시 | H.C. Wainwright | Buy |
| 2018-02-12 | 재확인 | B. Riley FBR, Inc. | Buy |
| 2018-02-09 | 재확인 | Chardan Capital Markets | Buy |
| 2017-12-08 | 개시 | B. Riley FBR, Inc. | Buy |
| 2017-06-12 | 개시 | Chardan Capital Markets | Buy |
| 2017-06-06 | 개시 | Ladenburg Thalmann | Buy |
| 2016-07-26 | 개시 | SunTrust | Buy |
| 2016-06-30 | 개시 | Rodman & Renshaw | Buy |
| 2015-03-17 | 재확인 | Stifel | Buy |
모두보기
Crescent Biopharma Inc 주식(CBIO)의 최신 뉴스
Crescent Biopharma Inc (CBIO) - MSN
Crescent Biopharma (NASDAQ:CBIO) Share Price Crosses Above 200-Day Moving Average – Here’s Why - Defense World
Crescent Biopharma Advances Cancer Therapy Pipeline - MSN
MSN Money - MSN
Is Crescent Biopharma Inc. (GKO0) stock protected from inflationJuly 2025 Institutional & Weekly Top Performers Watchlists - newser.com
Will Crescent Biopharma Inc. (GKO0) stock recover faster than industryJuly 2025 Opening Moves & Safe Entry Point Alerts - newser.com
Is Crescent Biopharma Inc. (GKO0) stock a top hedge fund pickExit Point & AI Powered Buy/Sell Recommendations - newser.com
What valuation ratios show for Crescent Biopharma Inc. (GKO0) stock2025 Top Decliners & Daily Entry Point Alerts - newser.com
Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives Average Recommendation of “Buy” from Analysts - Defense World
Crescent Biopharma (Nasdaq: CBIO) Approves 451,448-Share Inducement Options at $13.02 - Stock Titan
Crescent Biopharma (NASDAQ:CBIO) Upgraded by Wall Street Zen to Hold Rating - Defense World
Is Crescent Biopharma Inc. (GKO0) stock expanding market penetrationEntry Point & Long-Term Safe Return Strategies - newser.com
What market sentiment indicators show for Crescent Biopharma Inc. (GKO0) stock2025 Price Targets & Community Consensus Picks - newser.com
Can Crescent Biopharma Inc. (GKO0) stock beat analyst consensusBond Market & AI Forecasted Entry and Exit Points - newser.com
Crescent Biopharma to present preclinical data from CR-001 - MSN
Will Crescent Biopharma Inc. (GKO0) stock top growth indexes2025 Volume Leaders & Advanced Swing Trade Entry Alerts - newser.com
Crescent Biopharma, Inc. (C68.F) Valuation Measures & Financial Statistics - Yahoo! Finance Canada
Crescent Biopharma, Inc. (C68.F) Interactive Stock Chart - Yahoo! Finance Canada
Crescent Biopharma: Q3 Earnings Snapshot - theheraldreview.com
Crescent Biopharma Inc expected to post a loss of $2.02 a shareEarnings Preview - TradingView
Crescent Biopharma, Inc. (C68.F) Analyst Ratings, Estimates & Forecasts - Yahoo! Finance Canada
Crescent Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights - The Manila Times
[S-8] CRESCENT BIOPHARMA, INC. Employee Benefit Plan Registration | CBIO SEC FilingForm S-8 - Stock Titan
CRESCENT BIOPHARMA, INC. SEC 10-Q Report - TradingView
Crescent Biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
[8-K] CRESCENT BIOPHARMA, INC. Reports Material Event | CBIO SEC FilingForm 8-K - Stock Titan
Crescent Biopharma Inc (CBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.45%
1.13%
자본화:
|
볼륨(24시간):